Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$94.99 - $151.56 $8.17 Million - $13 Million
-85,990 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$127.69 - $165.85 $143,012 - $185,752
-1,120 Reduced 1.29%
85,990 $13.3 Million
Q3 2021

Nov 04, 2021

BUY
$102.33 - $144.73 $7.05 Million - $9.97 Million
68,865 Added 377.45%
87,110 $12.1 Million
Q2 2021

Aug 03, 2021

BUY
$113.03 - $155.64 $481,507 - $663,026
4,260 Added 30.46%
18,245 $2.39 Million
Q1 2021

May 03, 2021

BUY
$99.52 - $215.83 $1.39 Million - $3.02 Million
13,985 New
13,985 $2.13 Million
Q1 2019

May 13, 2019

SELL
$105.93 - $142.47 $6.64 Million - $8.93 Million
-62,671 Closed
0 $0
Q4 2018

Feb 05, 2019

BUY
$128.36 - $272.13 $2.11 Million - $4.48 Million
16,454 Added 35.6%
62,671 $8.5 Million
Q3 2018

Oct 29, 2018

SELL
$211.18 - $274.49 $6.55 Million - $8.52 Million
-31,030 Reduced 40.17%
46,217 $12.7 Million
Q2 2018

Aug 02, 2018

SELL
$150.77 - $207.98 $1.12 Million - $1.54 Million
-7,405 Reduced 8.75%
77,247 $16 Million
Q1 2018

May 09, 2018

SELL
$138.63 - $182.62 $3.08 Million - $4.06 Million
-22,235 Reduced 20.8%
84,652 $14 Million
Q4 2017

Jan 30, 2018

SELL
$128.36 - $147.04 $4.46 Million - $5.11 Million
-34,739 Reduced 24.53%
106,887 $14.6 Million
Q3 2017

Oct 30, 2017

BUY
$120.91 - $137.94 $17.1 Million - $19.5 Million
141,626
141,626 $19.3 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.42B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Mesirow Financial Investment Management Equity & Fixed Income Portfolio

Follow Mesirow Financial Investment Management Equity & Fixed Income and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.